You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

~ Buy the TRIPTODUR KIT (triptorelin pamoate) Drug Profile, 2024 PDF Report in the Report Store ~

TRIPTODUR KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Triptodur Kit, and what generic alternatives are available?

Triptodur Kit is a drug marketed by Azurity and is included in one NDA. There is one patent protecting this drug.

This drug has forty-six patent family members in thirty-one countries.

The generic ingredient in TRIPTODUR KIT is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.

DrugPatentWatch® Generic Entry Outlook for Triptodur Kit

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIPTODUR KIT?
  • What are the global sales for TRIPTODUR KIT?
  • What is Average Wholesale Price for TRIPTODUR KIT?
Summary for TRIPTODUR KIT
International Patents:46
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:TRIPTODUR KIT at DailyMed
Drug patent expirations by year for TRIPTODUR KIT

US Patents and Regulatory Information for TRIPTODUR KIT

TRIPTODUR KIT is protected by one US patents and one FDA Regulatory Exclusivity.

Patents protecting TRIPTODUR KIT

Slow release pharmaceutical composition made of microgranules
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

FDA Regulatory Exclusivity protecting TRIPTODUR KIT

TREATMENT OF PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER WITH CENTRAL PRECOCIOUS PUBERTY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity TRIPTODUR KIT triptorelin pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956-001 Jun 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Azurity TRIPTODUR KIT triptorelin pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956-001 Jun 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TRIPTODUR KIT

See the table below for patents covering TRIPTODUR KIT around the world.

Country Patent Number Title Estimated Expiration
Ukraine 99830 ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ С ПРОЛОНГИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, ИЗГОТОВЛЕННАЯ ИЗ МИКРОЧАСТИЦ;ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З ПРОЛОНГОВАНИМ ВИВІЛЬНЕННЯМ, ВИГОТОВЛЕНА З МІКРОЧАСТИНОК (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES) ⤷  Sign Up
Australia 2008259411 Slow release pharmaceutical composition made of microparticles ⤷  Sign Up
Japan 5419169 ⤷  Sign Up
Japan 2010529106 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.